Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tacrolimus vs Tyrosine + NB-UVB in Vitiligo
NCT07532330Completed
- Sponsor
- Minia University
- Start
- Aug 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of Tacrolimus Ointment 0.1% Iwaki and tyrosine in Vitiligo (3 arms), sponsored by Minia University. Primary endpoint: Clinical Improvement grade at 3 months. Started Aug 2025; status: completed.
02
Drugs
Tacrolimus Ointment 0.1% Iwakityrosine
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT07532330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07532330.